Clinical Trials on Complications of Prematurity in Japan
Total 577 results
-
Kyushu UniversityCompletedRetinopathy of PrematurityJapan
-
BayerRecruitingRetinopathy of Prematurity | Newborns | InfantsJapan
-
NobelpharmaCompleted
-
BayerRegeneron PharmaceuticalsCompletedAflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy (FIREFLEYE)Retinopathy of Prematurity (ROP)Spain, Singapore, Hong Kong, Korea, Republic of, Malaysia, Japan, Taiwan, Sweden, Portugal, Belgium, Argentina, Bulgaria, Italy, Austria, Brazil, Czechia, Greece, Hungary, Israel, Netherlands, Poland, Romania, Russian Federation, Slov... and more
-
BayerRegeneron PharmaceuticalsActive, not recruitingRetinopathy of Prematurity (ROP)Spain, Korea, Republic of, Singapore, Malaysia, Japan, Taiwan, Bulgaria, Italy, Argentina, Czechia, Greece, Israel, Netherlands, Portugal, Romania, Russian Federation, Slovakia, Sweden, Turkey, United Kingdom, Ukraine, Hungary, Belgium and more
-
Novartis PharmaceuticalsCompletedRetinopathy of Prematurity (ROP)United States, Austria, Belgium, Croatia, Czechia, Denmark, Egypt, France, Germany, Greece, Hungary, India, Italy, Japan, Malaysia, Romania, Russian Federation, Saudi Arabia, Slovakia, Taiwan, Turkey, United Kingdom, Lithuania, Estonia
-
OHB Neonatology Ltd.RecruitingIntraventricular Hemorrhage | Bronchopulmonary Dysplasia | Chronic Lung Disease of Prematurity | Retinopathy of Prematurity (ROP)Finland, United States, France, Italy, United Kingdom, Germany, Canada, Ireland, Japan, Netherlands, Portugal, Spain, Sweden
-
Novartis PharmaceuticalsCompletedRetinopathy of PrematurityUnited States, Austria, Belgium, Croatia, Czechia, Denmark, Egypt, Estonia, France, Germany, Greece, Hungary, India, Italy, Japan, Lithuania, Malaysia, Mexico, Poland, Romania, Russian Federation, Saudi Arabia, Slovakia, Taiwan, Turkey, United...
-
Kurume UniversityUnknownEffects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic ComplicationsJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP1941 | Pharmacokinetics of MitiglinideJapan
-
Okayama UniversityCompletedActivities of Daily Living | Diabetic Neuropathy PeripheralJapan
-
Osaka Metropolitan UniversityMayo Clinic; Istituto Ortopedico Rizzoli; Hospital for Special Surgery, New YorkActive, not recruitingTotal Knee Arthroplasty | Wear of Articular Bearing Surface of Prosthetic JointJapan
-
Bristol-Myers SquibbOno Pharma USA IncCompletedCancer of Head and Neck | Cancer of the Head | Cancer of the NeckJapan
-
Taisho Pharmaceutical Co., Ltd.Completed
-
Astellas Pharma IncCompletedA Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male SubjectsHealthy | Pharmacokinetics of ASP2408Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ValsartanJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP7991Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of ASP0456Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP015KJapan
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of QuetiapineJapan
-
Astellas Pharma IncCompletedA Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Healthy | Pharmacokinetics of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of AtorvastatinJapan
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of EnalaprilJapan
-
Kurume UniversityUnknownTo Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT ImagingJapan
-
Astellas Pharma IncCompletedHealthy Elderly Subject | Pharmacokinetic of YM150Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration Change of QuetiapineJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Plasma Concentration of MirabegronJapan
-
Shizuoka Cancer CenterCompletedEsophageal Neoplasms | Anastomotic Leak | Oxygen Deficiency | Esophagostomy ComplicationJapan
-
Astellas Pharma IncCompletedPost-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodineHealthy | Pharmacokinetics of Mirabegron and TolterodineJapan
-
Astellas Pharma IncToray Industries, IncCompletedHealthy Adult Male | Pharmacokinetics of TRK-100-STPJapan
-
Showa UniversityCompletedto Compare the Effect of Two Types of IOLs | on the Incidence of Cystoid Macular Edema | After Cataract SurgeryJapan
-
Kurashiki Central HospitalJapanese CTO PCI Expert Registry investigatorsRecruiting
-
Okayama UniversityUnknownArthropathy of Knee JointJapan
-
Sapporo Medical UniversityCompleted
-
BayerCompletedTreatment of Venous ThromboembolismJapan
-
Yosuke UchitomiRecruitingAdvanced Cancer | Recurrent Cancer | End of Life CareJapan
-
UMN Pharma Inc.CompletedHealthy | Immunogenicity of ASP7374Japan
-
Astellas Pharma IncCompletedPharmacokinetics of ASP3325 in Non-elderly, Healthy Adult Japanese Male and Female, and Caucasian Male SubjectsJapan
-
University of ToyamaNational Cancer Center, Korea; Samsung Medical Center; Seoul National University... and other collaboratorsActive, not recruitingDisease of Pancreatic or Periampullary LesionsJapan